-
3
-
-
33750327259
-
Natalizumab and progressive multifocal leucoencephalopathy
-
Berger JR (2006) Natalizumab and progressive multifocal leucoencephalopathy. Ann Rheum Dis 65 [Suppl 3]:48-53
-
(2006)
Ann Rheum Dis
, vol.65
, Issue.SUPPL. 3
, pp. 48-53
-
-
Berger, J.R.1
-
5
-
-
43549101765
-
-
10.1182/blood-2007-09-112052 18195093
-
Bonig 2008 Blood 111 3439 10.1182/blood-2007-09-112052 18195093
-
(2008)
Blood
, vol.111
, pp. 3439
-
-
Bonig1
-
6
-
-
38049000341
-
-
10.1016/j.jaut.2007.11.013 18191544
-
Boren 2008 J Autoimmun 30 90 10.1016/j.jaut.2007.11.013 18191544
-
(2008)
J Autoimmun
, vol.30
, pp. 90
-
-
Boren1
-
10
-
-
52249093352
-
-
10.1097/NEN.0b013e318180e631
-
Del 2008 J Neuropathol Exp Neurol 67 729 10.1097/NEN.0b013e318180e631
-
(2008)
J Neuropathol Exp Neurol
, vol.67
, pp. 729
-
-
Del1
-
11
-
-
34047148541
-
JC virus viremia in interferon-β-treated and untreated Italian multiple sclerosis patients and healthy controls
-
DOI 10.1080/13550280601094563, PII 776091738
-
Delbue 2007 J Neurovirol 13 73 10.1080/13550280601094563 17454451 (Pubitemid 46510147)
-
(2007)
Journal of NeuroVirology
, vol.13
, Issue.1
, pp. 73-77
-
-
Delbue, S.1
Guerini, F.R.2
Mancuso, R.3
Caputo, D.4
Mazziotti, R.5
Saresella, M.6
Ferrante, P.7
-
13
-
-
53649100111
-
-
10.1128/JCM.00844-08 18614652
-
Dumonceaux 2008 J Clin Microbiol 46 2829 10.1128/JCM.00844-08 18614652
-
(2008)
J Clin Microbiol
, vol.46
, pp. 2829
-
-
Dumonceaux1
-
14
-
-
52049100199
-
-
10.1097/QAI.0b013e31817bec64 18667930
-
Falcó 2008 J Acquir Immune Defic Syndr 49 26 10.1097/QAI. 0b013e31817bec64 18667930
-
(2008)
J Acquir Immune Defic Syndr
, vol.49
, pp. 26
-
-
Falcó1
-
16
-
-
70350570556
-
Plasma exchange augments leukocyte transmigration across an in vitro blood-brain barrier in Natalizumab-treated patients with multiple sclerosis
-
in press
-
Fox R, Man S, Tucky B (2009) Plasma exchange augments leukocyte transmigration across an in vitro blood-brain barrier in Natalizumab-treated patients with multiple sclerosis. Neurology in press
-
(2009)
Neurology
-
-
Fox, R.1
Man, S.2
Tucky, B.3
-
19
-
-
70350571253
-
Treatment of PML unfolding during monotherapy with Natalizumab
-
Montreal
-
Gold R, Wenning W, Haghikia A (2008) Treatment of PML unfolding during monotherapy with Natalizumab. ECTRIMS, Montreal
-
(2008)
ECTRIMS
-
-
Gold, R.1
Wenning, W.2
Haghikia, A.3
-
20
-
-
48949092317
-
Update on PML: Lessons from the HIV uninfected and new insights in pathogenesis and treatment
-
Hartman EA, Huang D (2008) Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment. Curr HIV/AIDS Rep 5:112-119
-
(2008)
Curr HIV/AIDS Rep
, vol.5
, pp. 112-119
-
-
Hartman, E.A.1
Huang, D.2
-
21
-
-
33744487388
-
Central nervous system infections - A potential complication of systemic immunotherapy
-
DOI 10.1097/01.wco.0000227037.70329.b0, PII 0001905220060600000008
-
Hemmer 2006 Curr Opin Neurol 19 271 10.1097/01.wco.0000227037.70329.b0 16702834 (Pubitemid 43804682)
-
(2006)
Current Opinion in Neurology
, vol.19
, Issue.3
, pp. 271-276
-
-
Hemmer, B.1
Frohman, E.2
Hartung, H.P.3
Stuve, O.4
-
22
-
-
0023860204
-
-
2827029
-
Houff 1988 N Engl J Med 318 301 2827029
-
(1988)
N Engl J Med
, vol.318
, pp. 301
-
-
Houff1
-
23
-
-
70350569947
-
-
18603304
-
Houff 2008 J Neuroimmunol 199 160 18603304
-
(2008)
J Neuroimmunol
, vol.199
, pp. 160
-
-
Houff1
-
24
-
-
70350568790
-
-
10.01.2009
-
http://clinicaltrials.gov/ct2/show/NCT00746941?term= mefloquine+and+pml&rank=1.Zugriffam 10.01.2009
-
-
-
-
25
-
-
70350570557
-
-
Zugriff am 10.01.2009
-
http://www.biogenidec.com/site/tysabri-information-center.html. Zugriff am 10.01.2009
-
-
-
-
26
-
-
70350566141
-
-
Zugriff am 10.01.2009
-
http://www.fda.gov/cder/drug/infopage/natalizumab/. Zugriff am 10.01.2009
-
-
-
-
27
-
-
70350575327
-
-
Zugriff am 10.01.2009
-
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Raptiva. Zugriff am 10.01.2009
-
-
-
-
28
-
-
57149104268
-
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
-
Accessed December 15
-
Iacobaeus E, Ryschkewitsch C, Gravell M et al (2008) Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA. Mult Scler Available at: http://www.ncbi.nlm.nih.gov/pubmed/18805840 [Accessed December 15, 2008]
-
(2008)
Mult Scler
-
-
Iacobaeus, E.1
Ryschkewitsch, C.2
Gravell, M.3
-
30
-
-
34047272106
-
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
-
DOI 10.1016/S1474-4422(07)70078-9, PII S1474442207700789
-
Kappos 2007 Lancet Neurol 6 431 10.1016/S1474-4422(07)70078-9 17434098 (Pubitemid 46551850)
-
(2007)
Lancet Neurology
, vol.6
, Issue.5
, pp. 431-441
-
-
Kappos, L.1
Bates, D.2
Hartung, H.-P.3
Havrdova, E.4
Miller, D.5
Polman, C.H.6
Ravnborg, M.7
Hauser, S.L.8
Rudick, R.A.9
Weiner, H.L.10
O'Connor, P.W.11
King, J.12
Radue, E.W.13
Yousry, T.14
Major, E.O.15
Clifford, D.B.16
-
31
-
-
33645815921
-
-
10.1191/135248506ms1264oa 16629416
-
Khalili 2006 Mult Scler 12 133 10.1191/135248506ms1264oa 16629416
-
(2006)
Mult Scler
, vol.12
, pp. 133
-
-
Khalili1
-
32
-
-
34147113927
-
Reactivation of JC virus and development of PML in patients with multiple sclerosis
-
DOI 10.1212/01.wnl.0000257832.38943.2b, PII 0000611420070327000007
-
Khalili 2007 Neurology 68 985 10.1212/01.wnl.0000257832.38943.2b 17389301 (Pubitemid 46569130)
-
(2007)
Neurology
, vol.68
, Issue.13
, pp. 985-990
-
-
Khalili, K.1
White, M.K.2
Lublin, F.3
Ferrante, P.4
Berger, J.R.5
-
33
-
-
70350567229
-
The effect of plasma exchange in accelerating clearance of natalizumab in patients with mulitple sclerosis: Results of the PLEX study
-
Khatri B, Fox R, Koo A (2009) The effect of plasma exchange in accelerating clearance of natalizumab in patients with mulitple sclerosis: results of the PLEX study. Neurology (in press)
-
(2009)
Neurology (In Press)
-
-
Khatri, B.1
Fox, R.2
Koo, A.3
-
34
-
-
22844439662
-
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
-
DOI 10.1056/NEJMoa051782
-
Kleinschmidt-DeMasters 2005 N Engl J Med 353 369 10.1056/NEJMoa051782 15947079 (Pubitemid 41132341)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.4
, pp. 369-374
-
-
Kleinschmidt-DeMasters, B.K.1
Tyler, K.L.2
-
36
-
-
2642572579
-
New insights into progressive multifocal leukoencephalopathy
-
DOI 10.1097/00019052-200406000-00019
-
Koralnik 2004 Curr Opin Neurol 17 365 10.1097/00019052-200406000-00019 15167073 (Pubitemid 38720991)
-
(2004)
Current Opinion in Neurology
, vol.17
, Issue.3
, pp. 365-370
-
-
Koralnik, I.J.1
-
37
-
-
33746825429
-
Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?
-
DOI 10.1002/ana.20933
-
Koralnik 2006 Ann Neurol 60 162 10.1002/ana.20933 16862584 (Pubitemid 44182391)
-
(2006)
Annals of Neurology
, vol.60
, Issue.2
, pp. 162-173
-
-
Koralnik, I.J.1
-
38
-
-
0032778957
-
-
10.3109/13550289909029484 10463865
-
Koralnik 1999 J Neurovirol 5 430 10.3109/13550289909029484 10463865
-
(1999)
J Neurovirol
, vol.5
, pp. 430
-
-
Koralnik1
-
40
-
-
34547892636
-
Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma
-
DOI 10.1212/01.wnl.0000267325.06000.d9, PII 0000611420070814000016
-
Kranick 2007 Neurology 69 704 10.1212/01.wnl.0000267325.06000.d9 17698796 (Pubitemid 47256017)
-
(2007)
Neurology
, vol.69
, Issue.7
, pp. 704-706
-
-
Kranick, S.M.1
Mowry, E.M.2
Rosenfeld, M.R.3
-
41
-
-
55449137632
-
-
10.1212/01.wnl.0000327671.91357.96 18936427
-
Krumbholz 2008 Neurology 71 1350 10.1212/01.wnl.0000327671.91357.96 18936427
-
(2008)
Neurology
, vol.71
, pp. 1350
-
-
Krumbholz1
-
42
-
-
50849120377
-
-
10.1016/j.jcv.2008.07.003 18701345
-
Landry 2008 J Clin Virol 43 247 10.1016/j.jcv.2008.07.003 18701345
-
(2008)
J Clin Virol
, vol.43
, pp. 247
-
-
Landry1
-
44
-
-
37249063841
-
TNFα blockade in human diseases: An overview of efficacy and safety
-
DOI 10.1016/j.clim.2007.08.012, PII S1521661607013265
-
Lin 2008 Clin Immunol 126 13 10.1016/j.clim.2007.08.012 17916445 (Pubitemid 350266448)
-
(2008)
Clinical Immunology
, vol.126
, Issue.1
, pp. 13-30
-
-
Lin, J.1
Ziring, D.2
Desai, S.3
Kim, S.4
Wong, M.5
Korin, Y.6
Braun, J.7
Reed, E.8
Gjertson, D.9
Singh, R.R.10
-
45
-
-
39849089879
-
-
10.1016/j.jneuroim.2007.11.007 18178259
-
Lindberg 2008 J Neuroimmunol 194 153 10.1016/j.jneuroim.2007.11.007 18178259
-
(2008)
J Neuroimmunol
, vol.194
, pp. 153
-
-
Lindberg1
-
47
-
-
61449227381
-
-
10.1001/archneur.65.12.noc80051
-
Martin 2008 Arch Neurol 65 1596 10.1001/archneur.65.12.noc80051
-
(2008)
Arch Neurol
, vol.65
, pp. 1596
-
-
Martin1
-
49
-
-
34548652293
-
Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: Insights into viral pathogenesis and disease prognosis
-
DOI 10.1080/13550280701381324, PII 781935110
-
Marzocchetti 2007 J Neurovirol 13 338 10.1080/13550280701381324 17849317 (Pubitemid 47400032)
-
(2007)
Journal of NeuroVirology
, vol.13
, Issue.4
, pp. 338-346
-
-
Marzocchetti, A.1
Sanguinetti, M.2
Di Giambenedetto, S.3
Cingolani, A.4
Fadda, G.5
Cauda, R.6
De Luca, A.7
-
50
-
-
0029794531
-
-
8794345
-
Monaco 1996 J Virol 70 7004 8794345
-
(1996)
J Virol
, vol.70
, pp. 7004
-
-
Monaco1
-
51
-
-
0034812844
-
JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor
-
DOI 10.1128/JVI.75.20.9687-9695.2001
-
Monaco 2001 J Virol 75 9687 10.1128/JVI.75.20.9687-9695.2001 11559801 (Pubitemid 32900103)
-
(2001)
Journal of Virology
, vol.75
, Issue.20
, pp. 9687-9695
-
-
Monaco, M.C.G.1
Sabath, B.F.2
Durham, L.C.3
Major, E.O.4
-
52
-
-
77949266426
-
Natalizumab significantly increases the cumulative probability of sustainded disability improvement in physical disability
-
Abstract
-
Munschauer F, Giovannoni G, Lublin F (2008) Natalizumab significantly increases the cumulative probability of sustainded disability improvement in physical disability. Mult Scler 14 [Suppl 1]:P474 (Abstract)
-
(2008)
Mult Scler
, vol.14
, Issue.SUPPL. 1
-
-
Munschauer, F.1
Giovannoni, G.2
Lublin, F.3
-
53
-
-
61549128409
-
-
10.1177/0961203308089445 18852230
-
Nived 2008 Lupus 17 1036 10.1177/0961203308089445 18852230
-
(2008)
Lupus
, vol.17
, pp. 1036
-
-
Nived1
-
54
-
-
41549096627
-
Results of clinical and magnetic resonance imaging analyses following cessatin of natalizumab dosin in patients with multiple sclerosis
-
Abstract
-
O'Connor P, Goodman A, Kappos L et al (2006) Results of clinical and magnetic resonance imaging analyses following cessatin of natalizumab dosin in patients with multiple sclerosis. Mult Scler 12 [Suppl. 1]:17 (Abstract)
-
(2006)
Mult Scler
, vol.12
, Issue.SUPPL. 1
, pp. 17
-
-
O'Connor, P.1
Goodman, A.2
Kappos, L.3
-
55
-
-
37149004518
-
The efficacy of natalizumab over 3 years of treatment in patients with relapsing multiple sclerosis
-
Abstract
-
O'Connor P, Goodman A, Kappos L et al (2007) The efficacy of natalizumab over 3 years of treatment in patients with relapsing multiple sclerosis. Neurology 66 [Suppl 1]:P06.082 (Abstract)
-
(2007)
Neurology
, vol.66
, Issue.SUPPL. 1
-
-
O'Connor, P.1
Goodman, A.2
Kappos, L.3
-
56
-
-
70350570555
-
-
Olsson T (2009) Karolinska Institut, Stockholm. Persönliche Mitteilung
-
Olsson T (2009) Karolinska Institut, Stockholm. Persönliche Mitteilung
-
-
-
-
57
-
-
41549115177
-
-
10.1007/s00277-007-0411-6 18064459
-
Pelosini 2008 Ann Hematol 87 405 10.1007/s00277-007-0411-6 18064459
-
(2008)
Ann Hematol
, vol.87
, pp. 405
-
-
Pelosini1
-
58
-
-
55849085378
-
-
10.1002/ana.21443 18688812
-
Perez-Liz 2008 Ann Neurol 64 379 10.1002/ana.21443 18688812
-
(2008)
Ann Neurol
, vol.64
, pp. 379
-
-
Perez-Liz1
-
59
-
-
54349123657
-
-
Pineton 2008 Gut 57 1633
-
(2008)
Gut
, vol.57
, pp. 1633
-
-
Pineton1
-
60
-
-
33644584352
-
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
-
DOI 10.1056/NEJMoa044397
-
Polman 2006 N Engl J Med 354 899 10.1056/NEJMoa044397 16510744 (Pubitemid 43313657)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.9
, pp. 899-910
-
-
Polman, C.H.1
O'Connor, P.W.2
Havrdova, E.3
Hutchinson, M.4
Kappos, L.5
Miller, D.H.6
Phillips, J.T.7
Lublin, F.D.8
Giovannoni, G.9
Wajgt, A.10
Toal, M.11
Lynn, F.12
Panzara, M.A.13
Sandrock, A.W.14
-
61
-
-
27744500993
-
Natalizumab and PML
-
DOI 10.1038/nn1005-1275, PII N10051275
-
Ransohoff 2005 Nat Neurosci 8 1275 10.1038/nn1005-1275 16189528 (Pubitemid 41630407)
-
(2005)
Nature Neuroscience
, vol.8
, Issue.10
, pp. 1275
-
-
Ransohoff, R.M.1
-
62
-
-
34250779802
-
Natalizumab for multiple sclerosis
-
DOI 10.1056/NEJMct071462
-
Ransohoff 2007 N Engl J Med 356 2622 10.1056/NEJMct071462 17582072 (Pubitemid 46961007)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.25
, pp. 2622-2629
-
-
Ransohoff, R.M.1
-
63
-
-
17644398787
-
-
15851719
-
Rice 2005 Neurology 64 1336 15851719
-
(2005)
Neurology
, vol.64
, pp. 1336
-
-
Rice1
-
64
-
-
33745602016
-
-
10.1007/0-387-32957-9-17 16626040
-
Roskopf 2006 Adv Exp Med Biol 577 228 10.1007/0-387-32957-9-17 16626040
-
(2006)
Adv Exp Med Biol
, vol.577
, pp. 228
-
-
Roskopf1
-
65
-
-
36148945609
-
Health-related quality of life in multiple sclerosis: Effects of natalizumab
-
DOI 10.1002/ana.21163
-
Rudick 2007 Ann Neurol 62 335 10.1002/ana.21163 17696126 (Pubitemid 350105948)
-
(2007)
Annals of Neurology
, vol.62
, Issue.4
, pp. 335-346
-
-
Rudick, R.A.1
Miller, D.2
Hass, S.3
Hutchinson, M.4
Calabresi, P.A.5
Confavreux, C.6
Galetta, S.L.7
Giovannoni, G.8
Havrdova, E.9
Kappos, L.10
Lublin, F.D.11
Miller, D.H.12
O'Connor, P.W.13
Phillips, J.T.14
Polman, C.H.15
Radue, E.-W.16
Stuart, W.H.17
Wajgt, A.18
Weinstock-Guttman, B.19
Wynn, D.R.20
Lynn, F.21
Panzara, M.A.22
more..
-
66
-
-
33644608613
-
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
-
DOI 10.1056/NEJMoa044396
-
Rudick 2006 N Engl J Med 354 911 10.1056/NEJMoa044396 16510745 (Pubitemid 43313658)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.9
, pp. 911-923
-
-
Rudick, R.A.1
Stuart, W.H.2
Calabresi, P.A.3
Confavreux, C.4
Galetta, S.L.5
Radue, E.-W.6
Lublin, F.D.7
Weinstock-Guttman, B.8
Wynn, D.R.9
Lynn, F.10
Panzara, M.A.11
Sandrock, A.W.12
-
67
-
-
4644347753
-
Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid
-
DOI 10.1016/j.jviromet.2004.06.021, PII S0166093404001934
-
Ryschkewitsch 2004 J Virol Methods 121 217 10.1016/j.jviromet.2004.06.021 15381359 (Pubitemid 39295712)
-
(2004)
Journal of Virological Methods
, vol.121
, Issue.2
, pp. 217-221
-
-
Ryschkewitsch, C.1
Jensen, P.2
Hou, J.3
Fahle, G.4
Fischer, S.5
Major, E.O.6
-
68
-
-
61549101481
-
-
10.1177/0961203308089435 18852228
-
Shprecher 2008 Lupus 17 1029 10.1177/0961203308089435 18852228
-
(2008)
Lupus
, vol.17
, pp. 1029
-
-
Shprecher1
-
69
-
-
33646347610
-
Immune surveillance in multiple sclerosis patients treated with natalizumab
-
DOI 10.1002/ana.20858
-
Stüve 2006 Ann Neurol 59 743 10.1002/ana.20858 16634029 (Pubitemid 43673151)
-
(2006)
Annals of Neurology
, vol.59
, Issue.5
, pp. 743-747
-
-
Stuve, O.1
Marra, C.M.2
Jerome, K.R.3
Cook, L.4
Cravens, P.D.5
Cepok, S.6
Frohman, E.M.7
Phillips, T.8
Arendt, G.9
Hemmer, B.10
Monson, N.L.11
Racke, M.K.12
-
70
-
-
33749588466
-
+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
-
DOI 10.1001/archneur.63.10.1383
-
Stüve 2006 Arch Neurol 63 1383 10.1001/archneur.63.10.1383 17030653 (Pubitemid 44547548)
-
(2006)
Archives of Neurology
, vol.63
, Issue.10
, pp. 1383-1387
-
-
Stuve, O.1
Marra, C.M.2
Bar-Or, A.3
Niino, M.4
Cravens, P.D.5
Cepok, S.6
Frohman, E.M.7
Phillips, J.T.8
Arendt, G.9
Jerome, K.R.10
Cook, L.11
Grand'Maison, F.12
Hemmer, B.13
Monson, N.L.14
Racke, M.K.15
-
71
-
-
33846969181
-
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: Possible interventions
-
DOI 10.1001/archneur.64.2.169
-
Stüve 2007 Arch Neurol 64 169 10.1001/archneur.64.2.169 17296831 (Pubitemid 46256555)
-
(2007)
Archives of Neurology
, vol.64
, Issue.2
, pp. 169-176
-
-
Stuve, O.1
Marra, C.M.2
Cravens, P.D.3
Singh, M.P.4
Hu, W.5
Lovett-Racke, A.6
Monson, N.L.7
Phillips, J.T.8
Cohen Tervaert, J.W.9
Nash, R.A.10
Hartung, H.-P.11
Kieseier, B.C.12
Racke, M.M.13
Frohman, E.M.14
Hemmer, B.15
-
72
-
-
61549088471
-
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
-
Stüve O, Cravens PD, Frohman EM et al (2009) Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology in press
-
(2009)
Neurology in Press
-
-
Stüve, O.1
Cravens, P.D.2
Frohman, E.M.3
-
73
-
-
0026751053
-
-
10.1002/ana.410310426 1316734
-
Tornatore 1992 Ann Neurol 31 454 10.1002/ana.410310426 1316734
-
(1992)
Ann Neurol
, vol.31
, pp. 454
-
-
Tornatore1
-
74
-
-
22844445587
-
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
-
DOI 10.1056/NEJMoa051586
-
Van 2005 N Engl J Med 353 362 10.1056/NEJMoa051586 (Pubitemid 41132340)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.4
, pp. 362-368
-
-
Van Assche, G.1
Van Ranst, M.2
Sciot, R.3
Dubois, B.4
Vermeire, S.5
Noman, M.6
Verbeeck, J.7
Geboes, K.8
Robberecht, W.9
Rutgeerts, P.10
-
75
-
-
41549130359
-
-
10.1212/01.wnl.0000265393.03231.e5 17872364
-
Vellinga 2008 Neurology 70 1150 10.1212/01.wnl.0000265393.03231.e5 17872364
-
(2008)
Neurology
, vol.70
, pp. 1150
-
-
Vellinga1
-
76
-
-
33747039795
-
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients
-
DOI 10.1212/01.wnl.0000227922.22293.93, PII 0000611420060808000008
-
Venkataramana 2006 Neurology 67 383 10.1212/01.wnl.0000227922.22293.93 16894096 (Pubitemid 44214957)
-
(2006)
Neurology
, vol.67
, Issue.3
, pp. 383-388
-
-
Venkataramana, A.1
Pardo, C.A.2
McArthur, J.C.3
Kerr, D.A.4
Irani, D.N.5
Griffin, J.W.6
Burger, P.7
Reich, D.S.8
Calabresi, P.A.9
Nath, A.10
-
77
-
-
52649134405
-
-
10.1136/gut.2007.145698 18436577
-
Verbeeck 2008 Gut 57 1393 10.1136/gut.2007.145698 18436577
-
(2008)
Gut
, vol.57
, pp. 1393
-
-
Verbeeck1
-
78
-
-
33644605483
-
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
-
DOI 10.1056/NEJMoa054693
-
Yousry 2006 N Engl J Med 354 924 10.1056/NEJMoa054693 16510746 (Pubitemid 43313659)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.9
, pp. 924-933
-
-
Yousry, T.A.1
Major, E.O.2
Ryschkewitsch, C.3
Fahle, G.4
Fischer, S.5
Hou, J.6
Curfman, B.7
Miszkiel, K.8
Mueller-Lenke, N.9
Sanchez, E.10
Barkhof, F.11
Radue, E.-W.12
Jager, H.R.13
Clifford, D.B.14
-
79
-
-
43549090004
-
-
10.1182/blood-2007-10-120329 18235044
-
Zohren 2008 Blood 111 3893 10.1182/blood-2007-10-120329 18235044
-
(2008)
Blood
, vol.111
, pp. 3893
-
-
Zohren1
-
80
-
-
67549085134
-
PML-JRJS in patients with HIV-infection. Clinical manifestation and treatment with steroids
-
Tan K, Roda R, Ostrow L et al (2009) PML-JRJS in patients with HIV-infection. Clinical manifestation and treatment with steroids. Neurology (in press)
-
(2009)
Neurology (In Press)
-
-
Tan, K.1
Roda, R.2
Ostrow, L.3
-
81
-
-
67549102670
-
Steroids for PML-JRJS. A double-edged sword?
-
Berger JR (2009) Steroids for PML-JRJS. A double-edged sword? Neurology (in press)
-
(2009)
Neurology (In Press)
-
-
Berger, J.R.1
|